BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24376772)

  • 1. Transcriptional targeting of primary and metastatic tumor neovasculature by an adenoviral type 5 roundabout4 vector in mice.
    Lu ZH; Kaliberov S; Sohn RE; Kaliberova L; Curiel DT; Arbeit JM
    PLoS One; 2013; 8(12):e83933. PubMed ID: 24376772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Tumor Neoangiogenesis via Targeted Adenoviral Vector to Achieve Effective Cancer Gene Therapy for Disseminated Neoplastic Disease.
    Lee M; Lu ZH; Li J; Kashentseva EA; Dmitriev IP; Mendonca SA; Curiel DT
    Mol Cancer Ther; 2020 Mar; 19(3):966-971. PubMed ID: 31907220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumors.
    Li HJ; Everts M; Yamamoto M; Curiel DT; Herschman HR
    Cancer Res; 2009 Jan; 69(2):554-64. PubMed ID: 19147569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting.
    Lu ZH; Kaliberov S; Zhang J; Muz B; Azab AK; Sohn RE; Kaliberova L; Du Y; Curiel DT; Arbeit JM
    Lab Invest; 2014 Aug; 94(8):881-92. PubMed ID: 24955893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting.
    Lu ZH; Dmitriev IP; Brough DE; Kashentseva EA; Li J; Curiel DT
    J Virol; 2020 May; 94(10):. PubMed ID: 32102889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA silencing improves the tumor specificity of adenoviral transgene expression.
    Card PB; Hogg RT; Gil Del Alcazar CR; Gerard RD
    Cancer Gene Ther; 2012 Jul; 19(7):451-9. PubMed ID: 22555510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector.
    Lu ZH; Kaliberov S; Sohn RE; Kaliberova L; Du Y; Prior JL; Leib DJ; Chauchereau A; Sehn JK; Curiel DT; Arbeit JM
    Oncotarget; 2017 Feb; 8(7):12272-12289. PubMed ID: 28103576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-targeted in vivo gene transfer coupled with histone deacetylase inhibitor depsipeptide (FK228) enhances adenoviral infection in rat renal cancer allograft model systems.
    Kobayashi M; Okada T; Murakami T; Ozawa K; Kobayashi E; Morita T
    Urology; 2007 Dec; 70(6):1230-6. PubMed ID: 18158067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy.
    Jin F; Xie Z; Kuo CJ; Chung LW; Hsieh CL
    Cancer Gene Ther; 2005 Mar; 12(3):257-67. PubMed ID: 15565180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells.
    Candolfi M; Curtin JF; Xiong WD; Kroeger KM; Liu C; Rentsendorj A; Agadjanian H; Medina-Kauwe L; Palmer D; Ng P; Lowenstein PR; Castro MG
    Mol Ther; 2006 Sep; 14(3):371-81. PubMed ID: 16798098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
    Wang ZX; Bian HB; Yang JS; De W; Ji XH
    Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transductional and transcriptional targeting of adenovirus for clinical applications.
    Glasgow JN; Bauerschmitz GJ; Curiel DT; Hemminki A
    Curr Gene Ther; 2004 Mar; 4(1):1-14. PubMed ID: 15032610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral versus intravenous gene therapy using a transcriptionally targeted viral vector in an orthotopic hepatocellular carcinoma rat model.
    Kim YI; Ahn BC; Ronald JA; Katzenberg R; Singh A; Paulmurugan R; Ray S; Gambhir SS; Hofmann LV
    J Vasc Interv Radiol; 2012 May; 23(5):704-11. PubMed ID: 22387029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective induction of tumor-associated antigens in murine pulmonary vasculature using double-targeted adenoviral vectors.
    Everts M; Kim-Park SA; Preuss MA; Passineau MJ; Glasgow JN; Pereboev AV; Mahasreshti PJ; Grizzle WE; Reynolds PN; Curiel DT
    Gene Ther; 2005 Jul; 12(13):1042-8. PubMed ID: 15789059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent antitumor efficacy of interleukin-18 delivered by conditionally replicative adenovirus vector in renal cell carcinoma-bearing nude mice via inhibition of angiogenesis.
    Zheng JN; Pei DS; Sun FH; Liu XY; Mao LJ; Zhang BF; Wen RM; Xu W; Shi Z; Liu JJ; Li W
    Cancer Biol Ther; 2009 Apr; 8(7):599-606. PubMed ID: 19305163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
    Pereboeva L; Komarova S; Roth J; Ponnazhagan S; Curiel DT
    Gene Ther; 2007 Apr; 14(8):627-37. PubMed ID: 17251987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter.
    Haviv YS; van Houdt WJ; Lu B; Curiel DT; Zhu ZB
    Mol Cancer Ther; 2004 Jun; 3(6):687-91. PubMed ID: 15210854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.
    Xiong Z; Cheng Z; Zhang X; Patel M; Wu JC; Gambhir SS; Chen X
    J Nucl Med; 2006 Jan; 47(1):130-9. PubMed ID: 16391197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus vector covalently conjugated to polyethylene glycol with a cancer-specific promoter suppresses the tumor growth through systemic administration.
    Yao X; Yoshioka Y; Morishige T; Eto Y; Narimatsu S; Mizuguchi H; Mukai Y; Okada N; Nakagawa S
    Biol Pharm Bull; 2010; 33(6):1073-6. PubMed ID: 20522982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer.
    Lucas T; Benihoud K; Vigant F; Schmidt CQ; Wortmann A; Bachem MG; Simmet T; Kochanek S
    PLoS One; 2015; 10(2):e0117254. PubMed ID: 25692292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.